Dawnrays Pharmaceutical (Holdings) Limited

Announcements & Notices       

2018-November-27	VOLUNTARY ANNOUNCEMENT-PASSING OF CONSISTENCY EVALUATION FOR "ENTECAVIR DISPERSIBLE TABLETS 0.5mg" and "AMLODIPINE BESYLATE TABLETS 5mg" (in PDF)
2018-August-23	ANNOUNCEMENT OF INTERIM RESULTS FOR THE SIX MONTHS ENDED 30 JUNE 2018 (in PDF)
2018-August-10	DATE OF BOARD MEETING (in PDF)
2018-August-3	POLL RESULTS OF THE EXTRAORDINARY GENERAL MEETING HELD ON 3 AUGUST 2018 AND ADJUSTMENTS TO THE OUTSTANDING OPTIONS (in PDF)
2018-July-17	NOTICE OF EXTRAORDINARY GENERAL MEETING (in PDF)
2018-July-11	(i)PROPOSED SPECIAL DIVIDEND; (ii) PROPOSED SHARE SUB-DIVISION (in PDF)
2018-June-27	DATE OF BOARD MEETING AND PROPOSED DECLARATION OF SPECIAL DIVIDEND (in PDF)
2018-May-25	LIST OF DIRECTORS AND THEIR ROLE AND FUNCTION (in PDF)
2018-May-25	(I) CHANGE OF INDEPENDENT NON-EXECUTIVE DIRECTOR; and (II)CHANGE IN COMPOSITION OF THE AUDIT COMMITTEE (in PDF)
2018-May-24	POLL RESULTS OF THE ANNUAL GENERAL MEETING HELD ON 24 MAY 2018 (in PDF)
2018-April-16	NOTICE OF ANNUAL GENERAL MEETING (in PDF)
2018-March-22	ANNOUNCEMENT OF THE ANNUAL RESULTS FOR THE YEAR ENDED 31 DECEMBER 2017 (in PDF)
2018-March-12	DATE OF BOARD MEETING (in PDF)
2018-February-23	LIST OF DIRECTORS AND THEIR ROLE AND FUNCTION (in PDF)
2018-February-23	RESIGNATION OF EXECUTIVE DIRECTOR (in PDF)
2018-January-8	LIST OF DIRECTORS AND THEIR ROLE AND FUNCTION (in PDF)
2018-January-5	APPOINTMENT OF AN EXECUTIVE DIRECTOR (in PDF)
2024	2024 Announcements & Notices
2023	2023 Announcements & Notices
2022	2022 Announcements & Notices
2021	2021 Announcements & Notices
2020	2020 Announcements & Notices
2019	2019 Announcements & Notices
2017	2017 Announcements & Notices